KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Gilead Sciences (GILD) Consolidated Net Income (2016 - 2025)

Gilead Sciences' Consolidated Net Income history spans 17 years, with the latest figure at $2.5 billion for Q4 2025.

  • For Q4 2025, Consolidated Net Income rose 41.86% year-over-year to $2.5 billion; the TTM value through Dec 2025 reached $8.9 billion, up 1748.85%, while the annual FY2025 figure was $8.5 billion, 1676.62% up from the prior year.
  • Consolidated Net Income reached $2.5 billion in Q4 2025 per GILD's latest filing, down from $3.1 billion in the prior quarter.
  • In the past five years, Consolidated Net Income ranged from a high of $3.1 billion in Q3 2025 to a low of -$4.2 billion in Q1 2024.
  • Average Consolidated Net Income over 5 years is $1.3 billion, with a median of $1.6 billion recorded in 2021.
  • Peak YoY movement for Consolidated Net Income: surged 8100.0% in 2023, then plummeted 523.88% in 2024.
  • A 5-year view of Consolidated Net Income shows it stood at $376.0 million in 2021, then surged by 334.31% to $1.6 billion in 2022, then fell by 13.29% to $1.4 billion in 2023, then grew by 25.85% to $1.8 billion in 2024, then surged by 41.86% to $2.5 billion in 2025.
  • Per Business Quant, the three most recent readings for GILD's Consolidated Net Income are $2.5 billion (Q4 2025), $3.1 billion (Q3 2025), and $2.0 billion (Q2 2025).